These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 29680373)
21. Prophylactic effect of Malarone against malaria: all good news? Nosten F Lancet; 2000 Dec; 356(9245):1864-5. PubMed ID: 11130375 [No Abstract] [Full Text] [Related]
22. The safety of atovaquone-proguanil for the prevention and treatment of malaria in pregnancy: A systematic review. Andrejko KL; Mayer RC; Kovacs S; Slutsker E; Bartlett E; Tan KR; Gutman JR Travel Med Infect Dis; 2019; 27():20-26. PubMed ID: 30654041 [TBL] [Abstract][Full Text] [Related]
23. Failure of atovaquone-proguanil chemoprophylaxis and chloroquine treatment in Plasmodium malariae infection. Visser R; de Mast Q; Munnix I; van der Ven A; Dofferhoff T Travel Med Infect Dis; 2016; 14(6):644-645. PubMed ID: 27546283 [No Abstract] [Full Text] [Related]
24. Atovaquone-proguanil (malarone): an effective treatment for uncomplicated Plasmodium falciparum malaria in travelers from Denmark. Thybo S; Gjorup I; Ronn AM; Meyrowitsch D; Bygberg IC J Travel Med; 2004; 11(4):220-3. PubMed ID: 15541224 [TBL] [Abstract][Full Text] [Related]
25. Safety of atovaquone-proguanil during pregnancy. Mayer RC; Tan KR; Gutman JR J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30544231 [TBL] [Abstract][Full Text] [Related]
26. Ketoconazole increases atovaquone exposure following concomitant administration with Malarone® in healthy subjects. Thapar MM; Ursing J; Ashton M; Bergqvist Y; Gil JP; Björkman A J Travel Med; 2022 Jul; 29(4):. PubMed ID: 35532299 [No Abstract] [Full Text] [Related]
27. A Case of Recrudescence Plasmodium falciparum Malaria Treated with Atovaquone-Proguanil. Kaman A; Tanır G; Akkaya B; Bayhan Gİ; Gayretli Aydın ZG; Aydın Teke T Turkiye Parazitol Derg; 2018 Sep; 42(3):233-236. PubMed ID: 30072357 [TBL] [Abstract][Full Text] [Related]
28. [Acquisition of atovaquone-proguanil resistance in imported falciparum malaria in a young child]. Aurégan C; Argy N; Hubert V; Aprahamian A; Clain J; Cheron G Presse Med; 2017 Mar; 46(3):344-346. PubMed ID: 28040348 [No Abstract] [Full Text] [Related]
29. In Vitro Analysis of the Interaction between Atovaquone and Proguanil against Liver Stage Malaria Parasites. Barata L; Houzé P; Boutbibe K; Zanghi G; Franetich JF; Mazier D; Clain J Antimicrob Agents Chemother; 2016 Jul; 60(7):4333-5. PubMed ID: 26926628 [TBL] [Abstract][Full Text] [Related]
31. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers. Toovey S; Nieforth K; Smith P; Schlagenhauf P; Adamcova M; Tatt I; Tomianovic D; Schnetzler G Travel Med Infect Dis; 2014; 12(6 Pt B):726-32. PubMed ID: 25443997 [TBL] [Abstract][Full Text] [Related]
32. Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa. Lachish T; Bar-Meir M; Eisenberg N; Schwartz E J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27625401 [TBL] [Abstract][Full Text] [Related]
33. Current status and replies to frequently posed questions on atovaquone plus proguanil (Malarone) for the prevention of malaria. Kain KC BioDrugs; 2003; 17 Suppl 1():23-8. PubMed ID: 12785875 [TBL] [Abstract][Full Text] [Related]
34. A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone/proguanil) for the prophylaxis of malaria in Zambia. Sukwa TY; Mulenga M; Chisdaka N; Roskell NS; Scott TR Am J Trop Med Hyg; 1999 Apr; 60(4):521-5. PubMed ID: 10348223 [TBL] [Abstract][Full Text] [Related]
35. A Case report of atovaquone/proguanil induced esophageal ulcers. Carnino L; Hulo C; Puppa G; Konan DB; Chappuis F J Travel Med; 2020 Nov; 27(7):. PubMed ID: 33043369 [No Abstract] [Full Text] [Related]
37. Plasmodium falciparum malaria occurring four years after leaving an endemic area. Vantomme B; Van Acker J; Rogge S; Ommeslag D; Donck J; Callens S Acta Clin Belg; 2016 Apr; 71(2):111-3. PubMed ID: 26312505 [TBL] [Abstract][Full Text] [Related]
38. Questionnaire-based analysis of atovaquone-proguanil compared with mefloquine in the chemoprophylaxis of malaria in non-immune Japanese travelers. Kato T; Okuda J; Ide D; Amano K; Takei Y; Yamaguchi Y J Infect Chemother; 2013 Feb; 19(1):20-3. PubMed ID: 22740189 [TBL] [Abstract][Full Text] [Related]
39. Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model. Deye GA; Miller RS; Miller L; Salas CJ; Tosh D; Macareo L; Smith BL; Fracisco S; Clemens EG; Murphy J; Sousa JC; Dumler JS; Magill AJ Clin Infect Dis; 2012 Jan; 54(2):232-9. PubMed ID: 22052893 [TBL] [Abstract][Full Text] [Related]
40. Bullous erythema multiforme after treatment with Malarone, a combination antimalarial composed of atovaquone and proguanil hydrochloride. Remich SA; Otieno W; Polhemus ME; Ogutu B; Walsh DS Trop Doct; 2008 Jul; 38(3):190-1. PubMed ID: 18628561 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]